HRP20080535T3 - Novo vezivanje agomelatina i inhibitora ponovnog uzimanja noradrenalina, farmaceutski pripravci koji ih sadrže - Google Patents

Novo vezivanje agomelatina i inhibitora ponovnog uzimanja noradrenalina, farmaceutski pripravci koji ih sadrže

Info

Publication number
HRP20080535T3
HRP20080535T3 HR20080535T HRP20080535T HRP20080535T3 HR P20080535 T3 HRP20080535 T3 HR P20080535T3 HR 20080535 T HR20080535 T HR 20080535T HR P20080535 T HRP20080535 T HR P20080535T HR P20080535 T3 HRP20080535 T3 HR P20080535T3
Authority
HR
Croatia
Prior art keywords
agomelatine
pharmaceutical compositions
compositions containing
reuptake inhibitor
new association
Prior art date
Application number
HR20080535T
Other languages
English (en)
Inventor
Mocaer Elisabeth
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20080535T3 publication Critical patent/HRP20080535T3/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Kombinacija spojeva, naznačena time, da je to kombinacija agomelatina ili N-[2-(7-metoksi-1-naftil)etil]acetamida i jednog od njegovih hidrata, kristalnih oblika i adicijskih soli s farmaceutski prihvatljivom kiselinom ili bazom i sredstvom za inhibiranje ponovnog preuzimanja noradrenalina ili sredstva koje omogućuje povećanje koncentracije noradrenalina na izvanstaničnoj razini. Patent sadrži još 4 patentna zahtjeva.
HR20080535T 2005-09-09 2008-11-05 Novo vezivanje agomelatina i inhibitora ponovnog uzimanja noradrenalina, farmaceutski pripravci koji ih sadrže HRP20080535T3 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509206A FR2890564B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
HRP20080535T3 true HRP20080535T3 (hr) 2008-12-31

Family

ID=36190808

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080535T HRP20080535T3 (hr) 2005-09-09 2008-11-05 Novo vezivanje agomelatina i inhibitora ponovnog uzimanja noradrenalina, farmaceutski pripravci koji ih sadrže

Country Status (39)

Country Link
US (1) US7622505B2 (hr)
EP (1) EP1769798B1 (hr)
JP (2) JP5395998B2 (hr)
KR (1) KR100863384B1 (hr)
CN (1) CN1927205A (hr)
AP (1) AP2615A (hr)
AR (1) AR056056A1 (hr)
AT (1) ATE404205T1 (hr)
AU (1) AU2006209368B2 (hr)
BR (1) BRPI0603759A (hr)
CA (1) CA2558782C (hr)
CY (1) CY1108319T1 (hr)
DE (1) DE602006002210D1 (hr)
DK (1) DK1769798T3 (hr)
EA (1) EA011650B1 (hr)
ES (1) ES2313590T3 (hr)
FR (1) FR2890564B1 (hr)
GE (1) GEP20094742B (hr)
GT (1) GT200600408A (hr)
HR (1) HRP20080535T3 (hr)
JO (1) JO2521B1 (hr)
MA (1) MA28505B1 (hr)
ME (2) ME02758B (hr)
MX (1) MXPA06010157A (hr)
MY (1) MY142260A (hr)
NO (1) NO338029B1 (hr)
NZ (1) NZ549725A (hr)
PE (1) PE20070429A1 (hr)
PL (1) PL1769798T3 (hr)
PT (1) PT1769798E (hr)
RS (1) RS50631B (hr)
SA (1) SA06270308B1 (hr)
SG (1) SG131030A1 (hr)
SI (1) SI1769798T1 (hr)
TW (1) TWI324513B (hr)
UA (1) UA83542C2 (hr)
UY (1) UY29778A1 (hr)
WO (1) WO2007028904A1 (hr)
ZA (1) ZA200607562B (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008247805A1 (en) * 2007-05-01 2008-11-13 Concert Pharmaceuticals Inc. Naphthyl(ethyl) acetamides
WO2008141033A1 (en) * 2007-05-08 2008-11-20 Auspex Pharmaceuticals Inc. Substituted naphthalenes
CN102342924A (zh) * 2010-08-05 2012-02-08 北京本草天源药物研究院 一种含有阿戈美拉汀的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
ZA989251B (en) * 1997-10-17 2000-04-10 Lilly Co Eli Potentiation of pharmaceuticals.
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
JP2005518439A (ja) * 2002-02-26 2005-06-23 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 抗痙攣性誘導体と抗片頭痛薬を含んで成る片頭痛治療用共治療薬
JP2004292445A (ja) * 2003-03-11 2004-10-21 Katsunori Nonogaki 糖尿病治療薬
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
AU2004271796A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Combination comprising an alpha-2-delta ligand and an SSRI and/or SNRI for treatment of depression and anxiety disorders

Also Published As

Publication number Publication date
AU2006209368A1 (en) 2007-03-29
AP2615A (en) 2013-03-14
FR2890564B1 (fr) 2007-10-19
UA83542C2 (uk) 2008-07-25
CA2558782C (fr) 2012-05-15
JP2007077147A (ja) 2007-03-29
JP2011088919A (ja) 2011-05-06
CY1108319T1 (el) 2014-02-12
FR2890564A1 (fr) 2007-03-16
DE602006002210D1 (de) 2008-09-25
BRPI0603759A (pt) 2007-05-15
AR056056A1 (es) 2007-09-12
CA2558782A1 (fr) 2007-03-09
JO2521B1 (en) 2010-03-17
EP1769798A1 (fr) 2007-04-04
PE20070429A1 (es) 2007-06-02
AP2008004378A0 (en) 2008-04-30
MXPA06010157A (es) 2007-03-08
GEP20094742B (en) 2009-07-27
ME02767B (me) 2010-06-30
MY142260A (en) 2010-11-15
SA06270308B1 (ar) 2011-10-08
US7622505B2 (en) 2009-11-24
KR100863384B1 (ko) 2008-10-13
JP5395998B2 (ja) 2014-01-22
GT200600408A (es) 2007-05-21
NZ549725A (en) 2008-03-28
DK1769798T3 (da) 2008-11-24
SI1769798T1 (sl) 2008-12-31
NO20064048L (no) 2007-03-12
KR20070029606A (ko) 2007-03-14
PL1769798T3 (pl) 2008-12-31
ES2313590T3 (es) 2009-03-01
ZA200607562B (en) 2008-05-28
CN1927205A (zh) 2007-03-14
ATE404205T1 (de) 2008-08-15
US20070060654A1 (en) 2007-03-15
NO338029B1 (no) 2016-07-25
TW200744570A (en) 2007-12-16
MA28505B1 (fr) 2007-04-03
SG131030A1 (en) 2007-04-26
WO2007028904A1 (fr) 2007-03-15
UY29778A1 (es) 2006-10-31
ME02758B (me) 2010-06-30
AU2006209368B2 (en) 2012-07-19
EA011650B1 (ru) 2009-04-28
TWI324513B (en) 2010-05-11
EP1769798B1 (fr) 2008-08-13
RS50631B (sr) 2010-06-30
PT1769798E (pt) 2008-09-18
EA200601410A1 (ru) 2007-04-27

Similar Documents

Publication Publication Date Title
RS52306B (en) CO-CRYSTALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE CO-CRYSTALS
MEP6208A (hr) Kombinacija inhibitora resorbcije serotonina i 5-ht2c antagonista inverznog agonista ili djelomičnog agonista
HRP20110230T1 (hr) Derivati alfa-aminoamida korisni u tretmanu poremećaja uzrokovanih ovisnošću
BRPI0913457A2 (pt) "composto, composição farmacêutica, e, uso do composto"
EA201070619A1 (ru) Карбоксамидные, сульфонамидные и аминовые соединения от метаболических нарушений
MX2007013065A (es) Derivados de dihidrobenzofurano y usos de los mismos.
CL2004000382A1 (es) Tetrahidroisoquinolinas sustituidas, proceso de preparacion, y composicion farmaceutica, utiles en el tratamiento y prevencion de estados patologicos que se alivian con un agonista de 5-ht6.
EA201490453A1 (ru) Замещенные аналоги (e)-n-(1-фенилэтилиден)бензогидразида в качестве ингибиторов деметилазы гистонов
AR080328A1 (es) Tienopirimidinas que contienen un grupo alquilo sustituido inhibidoras de quinasas mnk1 y/o mnk2, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento de trastornos metabolicos tales como diabetes y obesidad, y trastornos hiperproliferativos, entre otros
ATE440833T1 (de) Antithrombotische diamide
EA200702072A1 (ru) Фенилсодержащие n-ацильные производные аминов и аминокислот, способ их получения, фармацевтическая композиция и их применение
RS54439B1 (en) PHARMACEUTICAL COMBINATION FOR TREATMENT OF PAIN
RS51485B (en) USE OF AGOMELATIN FOR OBTAINING MEDICINES INTENDED FOR TREATMENT OF GENERALIZED ANXIETY DISORDER
HRP20080535T3 (hr) Novo vezivanje agomelatina i inhibitora ponovnog uzimanja noradrenalina, farmaceutski pripravci koji ih sadrže
WO2011011420A3 (en) 3, 4-methylenedioxyphenyl inhibitors of gaba aminotransferase and/or gaba reuptake transporter inhibitor
WO2007120725A3 (en) Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
AR047553A1 (es) La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
EA200801875A1 (ru) Антагонист cd 80
RS52260B (en) N- (2-hydroxyethyl) -N-methyl-4- (quinoline-8-yl (1- (thiazol-4-ylmethyl) piperidin-4-ylidene) methyl) benzamide, a process for its production as well as its use for treatment PAIN, TENSION AND DEPRESSION
RS51676B (en) USE OF AGOMELATIN FOR OBTAINING MEDICINES FOR SMITH-MAGENIS SYNDROME TREATMENT
RS51079B (sr) Novi naftalenski derivati, postupak njihove proizvodnje i farmaceutske smeše koje ih sadrže
RS51659B (en) THE USE OF AGOMELATIN FOR OBTAINING MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS
AR072917A1 (es) Composiciones para el tratamiento de la rosacea
RS51494B (en) THE USE OF AGOMELATIN FOR OBTAINING MEDICINES FOR THE TREATMENT OF PERIVENTRICULAR LEUKOMALATION
EA200600101A1 (ru) Лечение депрессии и других аффективных расстройств